An interventional study of IMPROVE Protocol in Pain and Opioid Use, sponsored by Wake Forest University Health Sciences. Withdrawn at 12 sites in United States. Per ClinicalTrials.gov, last updated 2022-04-21.
Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Health services research
The goal of the proposed study is to develop and implement a comprehensive strategy to address pain management in the inpatient setting while appropriately managing pain and optimizing patient safety in the inpatient setting. This strategy involves developing a new health Information Technology tool in the Omnicell and electronic medical record, implementing a "menu" of pain management and relaxation strategies, and developing educational materials for staff and patients to change the culture of pain management.
The goal of the proposed study is to develop and implement a comprehensive strategy to address pain management in the inpatient setting while appropriately managing pain and optimizing patient safety in the inpatient setting. This strategy involves developing a new health Information Technology tool in the Omnicell and electronic medical record, implementing a "menu" of pain management and relaxation strategies, and developing educational materials for staff and patients to change the culture of pain management.
This intervention will be implemented throughout CHS hospitals, using a stepped wedge design to guide rollout. The initial pilot will be conducted in the trauma inpatient units at Carolinas Medical Center. All patients admitted to the two primary trauma units (11A and 11 Tower) during the pilot study period will be included in the evaluation.
Exclusion Criteria:
The intervention is composed of 4 parts: 1) a multidisciplinary team that recommends, develops, approves, monitors the components of the intervention and training? 2) monitoring of medication sedation risk using established scale 3) restriction of medication dispensing via enhanced technology 4) health professional training on multimodality pain management including complementary and alternative therapies.
Other: IMPROVE Protocol
Treatment of patients in the usual manner based on their diagnosis and resources available at that site.
Comprehensive pain management protocol
Use of Opioid Overdose Reversal Treatment
Incidence of administration of opioid reversal agent
Time frame: Patient's entire length of stay in the hospital, up to 3 months
Pain
Average daily pain scores (VAS)
Time frame: Patient's entire length of stay in the hospital, up to 3 months
Oversedation without naloxone
Incidence of patient oversedation (Pasero \> 2 or associated diagnosis code)
Time frame: Patient's entire length of stay in the hospital, up to 3 months
Multimodal Therapy
Percentage of patients receiving multimodal pain management
Time frame: Patient's entire length of stay in the hospital, up to 3 months
Average Daily MME
Morphine Milligram Equivalent Dosing for Opioid Medications
Time frame: Patient's entire length of stay in the hospital, up to 3 months
Plan to share: No — No IPD will be made available to other researchers.
No publications or documents are linked to this record.
This study is withdrawn, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Wake Forest University Health Sciences